ACT News Alert Actavis Inc (ACT) 269.60 11/18/2014 20:31:03
Post# of 273311
Posted On: 11/18/2014 9:31:05 PM
Actavis Inc (ACT) 269.60 $ACT
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
at The Street - 1 hr 20 mins ago
It's hard to be skeptical about high-flying stocks when the bulls are making money right now, Cramer says.
MMM: 160.15 (+1.46), AMZN: 324.93 (+1.88), JEC: 47.70 (+0.47), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), BX: 32.61 (+0.59), DPLO: 24.01 (-0.09), UNH: 98.19 (+1.72), DECK: 92.20 (-0.52), COLM: 41.65 (+0.20), ALKS: 52.94 (+1.30), ADT: 35.37 (-0.03), CELG: 106.78 (+2.42), VE: 17.88 (+0.21), URBN: 28.79 (-2.04), AGN: 213.37 (+4.17), HLT: 25.61 (+0.19), AA: 17.16 (+0.33), RIG: 25.85 (-0.35), WMB: 54.54 (+0.23), PF: 32.48 (-1.24), PPG: 208.50 (+3.17), WPZ: 52.50 (+0.52)
Actavis'
at Investor's Business Daily - 2 hrs 48 mins ago
Actavis' (ACT) $66 bil takeover of Allergan (AGN) gets activist investor William Ackman's support, said Reuters. Ackman will reportedly withdraw a special shareholder meeting request at Allergan. Actavis shares jumped 8.7% to 269.60. Allergan rose 2%...
AGN: 213.37 (+4.17), ACT: 269.60 (+21.66)
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:05PM CST
Celldex Therapeutics announced encouraging interim update from the phase II ReACT study evaluating the use of rindopepimut.
ACT: 269.60 (+21.66), CLDX: 17.72 (-0.53), ABBV: 66.05 (+1.01)
Vipshop, Jack in the Box Rise In After-Hours Trading
at Investor's Business Daily - Tue Nov 18, 4:04PM CST
Stocks finished higher Tuesday, with the Dow Jones industrial average and the S&P 500 making fresh all-time highs and the Nasdaq overcoming Monday's weakness with a 14 1/2-year high. Volume was higher than Monday on the NYSE and slightly lower on the...
AGN: 213.37 (+4.17), JACK: 71.50 (+1.21), ACT: 269.60 (+21.66), VIPS: 23.71 (-0.28)
Market News: Actavis Plc, SunEdison Inc, Halliburton Company
at The Street - Tue Nov 18, 3:54PM CST
Investors' confidence on the U.S. economy increased due to better-than-expected corporate earnings and economic data The stock markets in the United States rallied amid investors' speculation that...
ACT: 269.60 (+21.66), TERP: 32.75 (+6.91), SUNE: 21.48 (+4.87), HAL: 48.54 (-0.69), BHI: 63.55 (-1.68)
Stocks Hit New Milestones; BitAuto Rebounds
at Investor's Business Daily - Tue Nov 18, 3:17PM CST
Stocks reached new milestones Tuesday following a mixed performance in the prior session. The Nasdaq made back Monday's loss and then some as it rallied 0.7% to a 14-1/2-year high. The S&P 500 and the Dow Jones industrial average climbed 0.5% and...
AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), BITA: 93.99 (+4.61), BABA: 110.81 (-3.44)
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
at The Street - Tue Nov 18, 3:09PM CST
Three cheers for the S&P 500 which closed the session at an all-time high for a fifth-consecutive session.
SPLS: 12.76 (-0.21), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), MDT: 72.47 (+3.28), XOM: 94.87 (-0.24), AGN: 213.37 (+4.17), URBN: 28.79 (-2.04), TJX: 61.64 (+0.10), GILD: 103.71 (+3.27), TOT: 58.40 (+1.14), TGT: 67.51 (+0.38), LOW: 58.53 (-0.36), CVX: 115.47 (-0.28)
Zoetis 2015 Guidance Misses As Buyout Theories Abound
at Investor's Business Daily - Tue Nov 18, 2:15PM CST
Animal-health giant Zoetis (ZTS) offered 2015 guidance below the Street's consensus along with longer-term financial goals at its analyst day Tuesday. After a brief halt in trading for the early-afternoon announcement, the stock was down more than 1%...
AGN: 213.37 (+4.17), ZTS: 44.19 (-0.04), ABT: 43.70 (-0.01), ACT: 269.60 (+21.66), VRX: 141.94 (+5.21), PFE: 30.59 (+0.27)
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
at Investor's Business Daily - Tue Nov 18, 1:38PM CST
Drugmakers clustered near the top of IBD's Stocks On The Move list Tuesday afternoon. Actavis (ACT), an Ireland-based maker of generic and branded drugs, shot up more than 7% in huge volume in Tuesday afternoon trading on the stock market today. That...
AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), TARO: 148.66 (+1.47), GILD: 103.71 (+3.27)
Stock Market Today: S&P 500 Rallies as Oil Falls Below $75 a Barrel
at The Street - Tue Nov 18, 1:23PM CST
The S&P 500 smashes its last intraday record high, moving higher after oil falls below $75 a barrel.
URBN: 28.79 (-2.04), AGN: 213.37 (+4.17), HD: 95.98 (-2.05), ACT: 269.60 (+21.66), TERP: 32.75 (+6.91), MDT: 72.47 (+3.28), GILD: 103.71 (+3.27), SUNE: 21.48 (+4.87), HIMX: 6.44 (-0.46), AAPL: 115.47 (+1.48), NOK: 7.93 (+0.26)
Stocks Hold Near Fresh Milestones; Actavis Hits New High
at Investor's Business Daily - Tue Nov 18, 12:33PM CST
Stocks were near their best levels of the session Tuesday afternoon amid news from Japan and a jump in homebuilder confidence. The Nasdaq rose 0.7%. Earlier, it touched a fresh 14-1/2-year high. The S&P 500 climbed 0.5% to an all-time high....
AGN: 213.37 (+4.17), VIPS: 23.71 (-0.28), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), BITA: 93.99 (+4.61)
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Nov 18, 12:20PM CST
This acquisition will place Actavis among the top 10 pharma companies based on sales.
AGN: 213.37 (+4.17), BIIB: 305.56 (+3.14), ACT: 269.60 (+21.66), VRX: 141.94 (+5.21)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 148.61 (+2.65), AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), PPH: 65.57 (+1.06), ACT: 269.60 (+21.66), XPH: 111.31 (+2.17)
Teva wins Actonel patent appeal
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:06AM CST
ACT: 269.60 (+21.66), MYL: 56.24 (+1.11), TEVA: 57.23 (-0.01)
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - Tue Nov 18, 10:47AM CST
There's a powerful collection of 'what's working.'
HON: 96.83 (+0.30), JAH: 67.03 (+0.34), CAH: 81.01 (+0.65), WMT: 83.79 (+0.22), PDCO: 46.61 (+0.35), EAT: 53.97 (+0.01), UPS: 106.03 (-0.44), JACK: 71.50 (+1.21), DLTR: 61.99 (+0.52), TGT: 67.51 (+0.38), COST: 139.21 (+0.74), AAL: 45.05 (+1.36), DG: 66.17 (+0.87), LOW: 58.53 (-0.36), MSFT: 48.74 (-0.72), HSIC: 132.39 (+1.45), BCR: 167.36 (+2.55), MCK: 207.99 (+3.61), IP: 54.98 (+0.14), EW: 127.88 (+1.65), FDO: 78.85 (-0.01), AZO: 568.59 (+0.53), MCD: 96.41 (+0.44), SHW: 241.32 (+2.01), XRAY: 53.11 (+0.50), AN: 57.73 (+0.39), F: 15.50 (-0.04), ACT: 269.60 (+21.66), BDX: 130.94 (+1.40), VRX: 141.94 (+5.21), MDT: 72.47 (+3.28), SNA: 136.02 (+1.13), GMCR: 157.10 (+2.60), AGN: 213.37 (+4.17), KMX: 55.13 (+0.47), YHOO: 51.75 (-0.62), WHR: 177.22 (+1.67), CMG: 658.09 (-0.23), AAPL: 115.47 (+1.48), AMZN: 324.93 (+1.88), HD: 95.98 (-2.05), ORLY: 178.57 (+1.27), FRGI: 56.02 (+0.36), ABC: 89.76 (+0.75), TJX: 61.64 (+0.10), GM: 32.27 (-0.04), JWN: 73.52 (+0.25), ROST: 81.28 (-0.06)
Actavis (ACT) Is Today's Unusual Social Activity Stock
at The Street - Tue Nov 18, 10:14AM CST
Trade-Ideas LLC identified Actavis (ACT) as an unusual social activity candidate
ACT: 269.60 (+21.66)
One Factor Driving Up Actavis (ACT) Stock Today
at The Street - Tue Nov 18, 10:06AM CST
Actavis (ACT) shares continue to climb as analysts at Citigroup (C) raised the company's price target following its purchase of Allergan (AGN) for $66 billion.
ACT: 269.60 (+21.66)
Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 9:10AM CST
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 213.37 (+4.17), ACT: 269.60 (+21.66), EOG: 97.67 (+1.32), HAL: 48.54 (-0.69), HP: 77.90 (-0.35), MRO: 32.06 (+0.24), BHI: 63.55 (-1.68)
Will Pfizer's Dividend Be Safe?
Todd Campbell, The Motley Fool - Motley Fool - Tue Nov 18, 8:29AM CST
Source: Pfizer via Facebook. Pfizer (NYSE: PFE) may be one of the planet's largest drugmakers, but it's been navigating a series of sales-crunching patent expirations that has investors wondering if the company's dividend payout will remain...
ACT: 269.60 (+21.66), PFE: 30.59 (+0.27), TEVA: 57.23 (-0.01)
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
at The Street - 1 hr 20 mins ago
It's hard to be skeptical about high-flying stocks when the bulls are making money right now, Cramer says.
MMM: 160.15 (+1.46), AMZN: 324.93 (+1.88), JEC: 47.70 (+0.47), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), BX: 32.61 (+0.59), DPLO: 24.01 (-0.09), UNH: 98.19 (+1.72), DECK: 92.20 (-0.52), COLM: 41.65 (+0.20), ALKS: 52.94 (+1.30), ADT: 35.37 (-0.03), CELG: 106.78 (+2.42), VE: 17.88 (+0.21), URBN: 28.79 (-2.04), AGN: 213.37 (+4.17), HLT: 25.61 (+0.19), AA: 17.16 (+0.33), RIG: 25.85 (-0.35), WMB: 54.54 (+0.23), PF: 32.48 (-1.24), PPG: 208.50 (+3.17), WPZ: 52.50 (+0.52)
Actavis'
at Investor's Business Daily - 2 hrs 48 mins ago
Actavis' (ACT) $66 bil takeover of Allergan (AGN) gets activist investor William Ackman's support, said Reuters. Ackman will reportedly withdraw a special shareholder meeting request at Allergan. Actavis shares jumped 8.7% to 269.60. Allergan rose 2%...
AGN: 213.37 (+4.17), ACT: 269.60 (+21.66)
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:05PM CST
Celldex Therapeutics announced encouraging interim update from the phase II ReACT study evaluating the use of rindopepimut.
ACT: 269.60 (+21.66), CLDX: 17.72 (-0.53), ABBV: 66.05 (+1.01)
Vipshop, Jack in the Box Rise In After-Hours Trading
at Investor's Business Daily - Tue Nov 18, 4:04PM CST
Stocks finished higher Tuesday, with the Dow Jones industrial average and the S&P 500 making fresh all-time highs and the Nasdaq overcoming Monday's weakness with a 14 1/2-year high. Volume was higher than Monday on the NYSE and slightly lower on the...
AGN: 213.37 (+4.17), JACK: 71.50 (+1.21), ACT: 269.60 (+21.66), VIPS: 23.71 (-0.28)
Market News: Actavis Plc, SunEdison Inc, Halliburton Company
at The Street - Tue Nov 18, 3:54PM CST
Investors' confidence on the U.S. economy increased due to better-than-expected corporate earnings and economic data The stock markets in the United States rallied amid investors' speculation that...
ACT: 269.60 (+21.66), TERP: 32.75 (+6.91), SUNE: 21.48 (+4.87), HAL: 48.54 (-0.69), BHI: 63.55 (-1.68)
Stocks Hit New Milestones; BitAuto Rebounds
at Investor's Business Daily - Tue Nov 18, 3:17PM CST
Stocks reached new milestones Tuesday following a mixed performance in the prior session. The Nasdaq made back Monday's loss and then some as it rallied 0.7% to a 14-1/2-year high. The S&P 500 and the Dow Jones industrial average climbed 0.5% and...
AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), BITA: 93.99 (+4.61), BABA: 110.81 (-3.44)
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
at The Street - Tue Nov 18, 3:09PM CST
Three cheers for the S&P 500 which closed the session at an all-time high for a fifth-consecutive session.
SPLS: 12.76 (-0.21), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), MDT: 72.47 (+3.28), XOM: 94.87 (-0.24), AGN: 213.37 (+4.17), URBN: 28.79 (-2.04), TJX: 61.64 (+0.10), GILD: 103.71 (+3.27), TOT: 58.40 (+1.14), TGT: 67.51 (+0.38), LOW: 58.53 (-0.36), CVX: 115.47 (-0.28)
Zoetis 2015 Guidance Misses As Buyout Theories Abound
at Investor's Business Daily - Tue Nov 18, 2:15PM CST
Animal-health giant Zoetis (ZTS) offered 2015 guidance below the Street's consensus along with longer-term financial goals at its analyst day Tuesday. After a brief halt in trading for the early-afternoon announcement, the stock was down more than 1%...
AGN: 213.37 (+4.17), ZTS: 44.19 (-0.04), ABT: 43.70 (-0.01), ACT: 269.60 (+21.66), VRX: 141.94 (+5.21), PFE: 30.59 (+0.27)
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
at Investor's Business Daily - Tue Nov 18, 1:38PM CST
Drugmakers clustered near the top of IBD's Stocks On The Move list Tuesday afternoon. Actavis (ACT), an Ireland-based maker of generic and branded drugs, shot up more than 7% in huge volume in Tuesday afternoon trading on the stock market today. That...
AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), TARO: 148.66 (+1.47), GILD: 103.71 (+3.27)
Stock Market Today: S&P 500 Rallies as Oil Falls Below $75 a Barrel
at The Street - Tue Nov 18, 1:23PM CST
The S&P 500 smashes its last intraday record high, moving higher after oil falls below $75 a barrel.
URBN: 28.79 (-2.04), AGN: 213.37 (+4.17), HD: 95.98 (-2.05), ACT: 269.60 (+21.66), TERP: 32.75 (+6.91), MDT: 72.47 (+3.28), GILD: 103.71 (+3.27), SUNE: 21.48 (+4.87), HIMX: 6.44 (-0.46), AAPL: 115.47 (+1.48), NOK: 7.93 (+0.26)
Stocks Hold Near Fresh Milestones; Actavis Hits New High
at Investor's Business Daily - Tue Nov 18, 12:33PM CST
Stocks were near their best levels of the session Tuesday afternoon amid news from Japan and a jump in homebuilder confidence. The Nasdaq rose 0.7%. Earlier, it touched a fresh 14-1/2-year high. The S&P 500 climbed 0.5% to an all-time high....
AGN: 213.37 (+4.17), VIPS: 23.71 (-0.28), VRX: 141.94 (+5.21), ACT: 269.60 (+21.66), HD: 95.98 (-2.05), BITA: 93.99 (+4.61)
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Nov 18, 12:20PM CST
This acquisition will place Actavis among the top 10 pharma companies based on sales.
AGN: 213.37 (+4.17), BIIB: 305.56 (+3.14), ACT: 269.60 (+21.66), VRX: 141.94 (+5.21)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 148.61 (+2.65), AGN: 213.37 (+4.17), VRX: 141.94 (+5.21), PPH: 65.57 (+1.06), ACT: 269.60 (+21.66), XPH: 111.31 (+2.17)
Teva wins Actonel patent appeal
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:06AM CST
ACT: 269.60 (+21.66), MYL: 56.24 (+1.11), TEVA: 57.23 (-0.01)
Jim Cramer: Which Stocks Stand Out as Winners? Here's My List
at The Street - Tue Nov 18, 10:47AM CST
There's a powerful collection of 'what's working.'
HON: 96.83 (+0.30), JAH: 67.03 (+0.34), CAH: 81.01 (+0.65), WMT: 83.79 (+0.22), PDCO: 46.61 (+0.35), EAT: 53.97 (+0.01), UPS: 106.03 (-0.44), JACK: 71.50 (+1.21), DLTR: 61.99 (+0.52), TGT: 67.51 (+0.38), COST: 139.21 (+0.74), AAL: 45.05 (+1.36), DG: 66.17 (+0.87), LOW: 58.53 (-0.36), MSFT: 48.74 (-0.72), HSIC: 132.39 (+1.45), BCR: 167.36 (+2.55), MCK: 207.99 (+3.61), IP: 54.98 (+0.14), EW: 127.88 (+1.65), FDO: 78.85 (-0.01), AZO: 568.59 (+0.53), MCD: 96.41 (+0.44), SHW: 241.32 (+2.01), XRAY: 53.11 (+0.50), AN: 57.73 (+0.39), F: 15.50 (-0.04), ACT: 269.60 (+21.66), BDX: 130.94 (+1.40), VRX: 141.94 (+5.21), MDT: 72.47 (+3.28), SNA: 136.02 (+1.13), GMCR: 157.10 (+2.60), AGN: 213.37 (+4.17), KMX: 55.13 (+0.47), YHOO: 51.75 (-0.62), WHR: 177.22 (+1.67), CMG: 658.09 (-0.23), AAPL: 115.47 (+1.48), AMZN: 324.93 (+1.88), HD: 95.98 (-2.05), ORLY: 178.57 (+1.27), FRGI: 56.02 (+0.36), ABC: 89.76 (+0.75), TJX: 61.64 (+0.10), GM: 32.27 (-0.04), JWN: 73.52 (+0.25), ROST: 81.28 (-0.06)
Actavis (ACT) Is Today's Unusual Social Activity Stock
at The Street - Tue Nov 18, 10:14AM CST
Trade-Ideas LLC identified Actavis (ACT) as an unusual social activity candidate
ACT: 269.60 (+21.66)
One Factor Driving Up Actavis (ACT) Stock Today
at The Street - Tue Nov 18, 10:06AM CST
Actavis (ACT) shares continue to climb as analysts at Citigroup (C) raised the company's price target following its purchase of Allergan (AGN) for $66 billion.
ACT: 269.60 (+21.66)
Stock Market News for November 18, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 9:10AM CST
Markets ended its choppy run yesterday on a mixed note after Japan unexpectedly slipped into a recession
AGN: 213.37 (+4.17), ACT: 269.60 (+21.66), EOG: 97.67 (+1.32), HAL: 48.54 (-0.69), HP: 77.90 (-0.35), MRO: 32.06 (+0.24), BHI: 63.55 (-1.68)
Will Pfizer's Dividend Be Safe?
Todd Campbell, The Motley Fool - Motley Fool - Tue Nov 18, 8:29AM CST
Source: Pfizer via Facebook. Pfizer (NYSE: PFE) may be one of the planet's largest drugmakers, but it's been navigating a series of sales-crunching patent expirations that has investors wondering if the company's dividend payout will remain...
ACT: 269.60 (+21.66), PFE: 30.59 (+0.27), TEVA: 57.23 (-0.01)
(0)
(0)